The premise of this interview is to see what the landscape looks like with testing – diagnostic companies as we approach the vaccine salvation promised land, who will be the winners and losers?
SP Angel is an independent partnership providing creative, capital markets solutions to growing companies.
The Healthcare sector includes companies driving all facets of healthcare markets including biotechnology, pharmaceuticals, medical devices & technologies, and healthcare services.
The SP Angel Healthcare Team represents clients from across the industry, including companies at the forefront of biotechnology, pharmaceuticals, medical devices, digital health and healthcare services. Our team has established a solid reputation in helping clients secure private and public funding at every stage of their journey, from preclinical work to commercialisation, and sale/acquisition.
In addition to fundraising and public offerings, the Team provides advisory services on M&A transactions, due diligence, valuation, financial modelling and equity research. Further, SP Angel advises clients on multiple markets, including AIM, the Aquis Exchange and the Standard List.
Our research analysts are skilled in identifying and communicating investment ideas to both the generalist and specialist investor communities. This technical expertise is supported by a specialised sales and broking team with proven experience in funding healthcare companies at all stages of development, including via private capital raises, IPOs and secondary fundraises. Finally, an experienced corporate finance team ensures we provide our clients with the regulatory and strategic guidance required to deliver results in the highly regulated fields of finance and healthcare.
With an established reputation for market reach and successful execution of mandates, we have a strong track record across many key sectors including, Mining, Oil & Gas, Healthcare, Technology and Special Situations. The long-term client relationships we develop enable us to partner with our clients to help drive the growth of their businesses through rapidly changing market conditions.
SP Angel is a Member of the London Stock Exchange, an AIM Nominated Adviser and Broker and a NEX Exchange Corporate Adviser and is authorised and regulated by the Financial Conduct Authority (FCA).
© 2021 SP Angel Corporate Finance LLP is authorised and regulated by the Financial Conduct Authority. Registered in England No. OC317049. Registered Office: Prince Frederick House, 35-39 Maddox Street, London W1S 2PP.